• Aucun résultat trouvé

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings

N/A
N/A
Protected

Academic year: 2022

Partager "COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings"

Copied!
5
0
0

Texte intégral

(1)

Article

Reference

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings

NEHME, Mayssam, et al. & COVICARE TEAM

Abstract

Background: Coronavirus disease 2019 (COVID-19) has spread, causing a worldwide pandemic, and prolonged effects are emerging (1, 2). The term “long COVID” describes illness in persons who continue to report lasting effects after infection (3, 4). To date, little information exists about outpatient settings in this novel disease where 81% of cases are reportedly on the mild end of the spectrum (5). Informing patients and physicians about COVID-19 symptom evolution may help them recognize the time course of the disease, legitimize patients' concerns, and reassure them when possible. Messages around potentially persisting symptoms could also assist in reinforcing public health measures to avoid the spread of infection. Objective: To describe COVID-19 symptom evolution and persistence in an outpatient setting in Geneva, Switzerland, from day 1 through day 30 to 45 after diagnosis.

NEHME, Mayssam, et al . & COVICARE TEAM. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Annals of Internal Medicine , 2020, vol. 174, no. 5, p.

723-725

DOI : 10.7326/M20-5926 PMID : 33284676

Available at:

http://archive-ouverte.unige.ch/unige:155430

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

    © 2020 American College of Physicians 

Supplementary Material* 

 

Nehme M, Braillard O, Alcoba G, et al. COVID‐19 symptoms: longitudinal evolution and  persistence in outpatient settings. Ann Intern Med. 8 December 2020. [Epub ahead of print]. 

doi:10.7326/M20‐5926   

 

Supplement. Survey Data Collected   

 

* This supplementary material was provided by the authors to give readers further details on their  article. The material was reviewed but not copyedited.

(3)

Supplement. Survey data collected Record ID

Date

Unreachable Yes/No

Date of test Testing center

Hospitalization Yes/No

Date of hospitalization Date of symptoms onset

Risk factors (Yes/No, multiple options possible) Cardiovascular disease Hypertension

Diabetes

Chronic respiratory disease Cancer

Immunosuppression Other chronic disease Pregnancy

Symptoms (Yes/No, multiple options possible) Cough Dyspnea Fever (T >38C) Fatigue

Myalgias, arthralgias Headache

Rhinorrhea Odynodysphagia Anosmia/agueusia Abdominal pain Nausea/vomiting Diarrhea

Other Deteriorating clinical symptom Yes/No

Orientation (only one option possible) Follow-up every 2 days Follow-up every day End of follow-up Reason for end of follow-up (multiple options

possible)

Followed by primary care Physician

Patient’s wish Death

Out of canton Clinical recovery

Lost to follow-up (unreachable for 2 consecutive days)

D30-45 assessment Date of assessment Unreachable

Hospitalization Not hospitalized

Hospitalized for COVID-related reasons Hospitalized for non-COVID-related reasons

Current symptoms Yes/No

List symptoms (Yes/No, multiple options possible) Fatigue

Loss of appetite Myalgias

(4)

Arthralgias Back pain Fever > 38C Cough Dyspnea Chest pain Palpitations Headache Paresthesias Anosmia Agueusia

Odynodysphagia Nausea

Vomiting Diarrhea Abdominal pain Rash

Current symptom intensity (one option possible) Mild Moderate Severe

Symptom evolution (one option possible) Never disappeared Recurred

Fluctuates Most predominant symptom (one option possible) Fatigue

Loss of appetite Myalgias Arthralgias Back pain Fever > 38C Cough Dyspnea Chest pain Palpitations Headache Paresthesias Anosmia Agueusia

Odynodysphagia Nausea

Vomiting Diarrhea Abdominal pain Rash

Most worrisome symptom (one option possible) Fatigue

Loss of appetite Myalgias Arthralgias Back pain Fever > 38C Cough Dyspnea Chest pain Palpitations Headache Paresthesias

(5)

Anosmia Agueusia

Odynodysphagia Nausea

Vomiting Diarrhea Abdominal pain Rash

If back pain, specify: Few days

Most days All days

If fatigue, specify: Normal activity, no limitations in daily activity

Limited activity but capable to do light work (office work, cleaning)

Limited activity but <50% in bed during the day

>50% in bed, but not bedbound Bedbound

If dyspnea, specify Dyspnea only with strenuous exercise Dyspnea when hurrying or walking up a slight hill

Has to stop for breath when walking at own pace on flat surface

Stops for breath after walking 90 meters or after a few minutes Too breathless to leave house or breathless when dressing  

Références

Documents relatifs

This question was investigated by comparing electromyographical (EMO) activity of bilateral rectus abdominis (RA), external oblique (EO), and the lower abdominal stabilizers (LAS) of

This chapter presents the recommendations the guideline development group (GDG) developed to answer the “population, intervention, comparator and outcome” PICO questions on the use

Cardiac Chest Pain risk Stratification Pathway Acute Coronary syndrome suspected/under investigation. Intermediate risk Chest Pain

Clinically significant reduction in pain is more reliably observed in chronic rather than acute low back pain (strength of recommenda- tion: A, based on systematic review

Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.. Friedman BW, Dym AA, Davitt M, Holden

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing

Chest radiograph showing a grossly hyperinflated right hemithorax compared with the left: The right side appears hyperlucent, with absent normal bronchovascular lung

Interestingly, comparing patients with and without headache, for whom data were available at follow-up, and adjusting for age and gender, we observed shorter COVID-19 disease